LONDON, July 31, 2020 (GLOBE NEWSWIRE) — OKYO, the life sciences and biotechnology company, focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and
LONDON, July 31, 2020 (GLOBE NEWSWIRE) — OKYO, the life sciences and biotechnology company, focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and
Dr. Raj Patil is Sr. Director of Research & Development at OKYO Pharma speaks to Zak Mir. Dr. Patil brings more than 25 years of academic and pharmaceutical experience in